In vitro stimulation of insulin release by SL 84.0418, a new alpha 2-adrenoceptor antagonist.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  European Journal of Pharmacology

• Publication date

  1994-03-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0014-2999(94)90366-2PMID 7911430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonist.

  1993cited by this paper
• Stimulation of insulin secretion by the imidazoline alpha 2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site.

  1993cited by this paper
• Imidazoline antagonists of α2‐adrenoceptors increase insulin release in vitro by inhibiting ATP‐sensitive K+ channels in pancreatic β‐cells

  1992cited by this paper
• SL 84.0418: a novel, potent and selective alpha-2 adrenoceptor antagonist: in vitro pharmacological profile.

  1992cited by this paper
• Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells.

  1992cited by this paper
• Effect of an oral α2-adrenergic blocker (MK-912) on pancreatic islet function in non-insulin-dependent diabetes mellitus

  1991cited by this paper
• Block of ATP-regulated potassium channels by phentolamine and other alpha-adrenoceptor antagonists.

  1991cited by this paper
• Pre- and postsynaptic alpha-2 adrenoceptors as target for drug discovery.

  1991cited by this paper
• Effect of an oral alpha 2-adrenergic blocker (MK-912) on pancreatic islet function in non-insulin-dependent diabetes mellitus.

  1991cited by this paper
• Clonidine inhibits ATP-sensitive K+ channels in mouse pancreatic beta-cells.

  1991cited by this paper
• Mechanisms involved in stimulation of insulin secretion by the hypoglycaemic alpha-adrenergic antagonist, DG-5128.

  1991cited by this paper
• The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells.

  1991cited by this paper
• Clonidine inhibits ATP‐sensitive K+channels in mouse pancreatic β‐cells

  1991cited by this paper
• The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells

  1991cited by this paper
• Block of ATP‐regulated potassium channels by phentolamine and other α‐adrenoceptor antagonists

  1991cited by this paper
• Phentolamine and yohimbine inhibit ATP‐sensitive K+ channels in mouse pancreatic β‐cells

  1990cited by this paper
• Mechanisms of the stimulation of insulin release by arginine-vasopressin in normal mouse islets.

  1990cited by this paper
• Selective α2-adrenoceptor blockade does not enhance glucose-evoked insulin release

  1990cited by this paper
• Selective alpha 2-adrenoceptor blockade does not enhance glucose-evoked insulin release.

  1990cited by this paper
• Antihyperglycaemic effects of the new alpha-2 antagonist SL 84.0418 in the primate (macaca fascicularis) in comparison with idazoxan

  1990cited by this paper
• Effects of putative activators of K+ channels in mouse pancreatic β‐cells

  1989cited by this paper
• Effects of putative activators of K+ channels in mouse pancreatic beta-cells.

  1989cited by this paper
• Stress and Autonomic Nervous System in Type II Diabetes: A Hypothesis

  1988cited by this paper
• Properties and calcium‐dependent inactivation of calcium currents in cultured mouse pancreatic B‐cells.

  1988cited by this paper
• Highly potent and stereoselective effects of the benzoic acid derivative AZ‐DF 265 on pancreatic β‐cells

  1988cited by this paper
• Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes.

  1988cited by this paper
• Exaggerated peripheral responses to catecholamines contributes to stress-induced hyperglycemia in the ob/ob mouse.

  1987cited by this paper
• α-Adrenergic Blockade Improves Glucose-Potentiated Insulin Secretion in Non-Insulin-Dependent Diabetes Mellitus

  1987cited by this paper
• Alpha-adrenergic blockade improves glucose-potentiated insulin secretion in non-insulin-dependent diabetes mellitus.

  1987cited by this paper
• Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic β-cells

  1986cited by this paper
• Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion

  1986cited by this paper
• New α2-Adrenergic Blocker (DG-5128) Improves Insulin Secretion and In Vivo Glucose Disposal in NIDDM Patients

  1986cited by this paper
• A metabolite-regulated potassium channel in rat pancreatic B cells.

  1986cited by this paper
• SELECTIVE α2 RECEPTOR BLOCKADE FACILITATES THE INSULIN RESPONSE TO ADRENALINE BUT NOT TO GLUCOSE IN MAN

  1985cited by this paper
• Glucose dependent K+-channels in pancreaticβ-cells are regulated by intracellular ATP

  1985cited by this paper
• Studies on RX 781094: a selective, potent and specific antagonist of α2‐adrenoceptors

  1983cited by this paper
• Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.

  1983cited by this paper
• Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cells.

  1982cited by this paper
• Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the Islets of Langerhans.

  1981cited by this paper
• Adrenergic mechanisms in the hyperglycaemia and hyperinsulinaemia of diabetic KK mice

  1981cited by this paper
• α2-Adrenoceptors modulating insulin release from isolated pancreatic islets

  1980cited by this paper
• D-Glucose inhibits potassium efflux from pancreatic islet cells

  1978cited by this paper
• A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus.

  1976cited by this paper
• Effect of chronically administered L-dopa on dopa 5HTP decarboxylase and tyrosine and tryptophan hydroxylases in cat brain.

  1973cited by this paper

• Adrenoceptor Expression and Function in the Endocrine Pancreas.

  2024cites this paper
• Methylamine Activates Glucose Uptake in Human Adipocytes Without Overpassing Action of Insulin or Stimulating its Secretion in Pancreatic Islets

  2019cites this paper
• Agonists and antagonists targeting the different alpha2-adrenoceptor subtypes.

  2007cites this paper
• CONTROL OF ENVIRONMENTAL HEALTH AND REMOVAL OF RATS BY a2-ADRENERGIC ANTAGONIST AND POTASSIUM CHANNEL BLOCKER

  2006cites this paper
• Alpha2-adrenoceptor antagonist SL 84.0418 reduces the expression of neocortical spike-and-wave spindling episodes in DBA/2J mice.

  2003cites this paper
• Role of mu-opioid receptors in insulin release in the presence of inhibitory and excitatory secretagogues.

  2002cites this paper
• Imidazoline receptors: new targets for antihyperglycaemic drugs.

  1999cites this paper
• Mechanisms of the hypoglycemic effects of the alpha2-adrenoceptor antagonists SL84.0418 and deriglidole.

  1998cites this paper
• Effects of acute a2-blockade on insulin action and secretion in humans

  1998cites this paper
• Effects of acute alpha 2-blockade on insulin action and secretion in humans.

  1998cites this paper
• Imidazoline/guanidinium binding sites and their relation to inhibition of KATP channels in pancreatic B-cells

  1997cites this paper
• BTS 67 582 stimulates insulin secretion from perifused rat pancreatic islets.

  1997cites this paper
• Involvement of capsaicin-sensitive nerves in the regulation of glucose tolerance in diabetic rats.

  1996cites this paper
• Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells.

  1996cites this paper
• Chapter 17. Recent Advancements in the Discovery and Development of Agents for the Treatment of Diabetes.

  1995cites this paper
• Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.

  1995cites this paper
• Characterization of the Imidazoline Binding Site Involved in Regulation of Insulin Secretion fn1

  1995cites this paper
• Repeated Administration of SL 84.0418, a New Oral Antihyperglycaemic Agent

  1995cites this paper
• The imidazoline SL 84.0418 shows stereoselectivity in blocking alpha 2-adrenoceptors but not ATP-sensitive K+ channels in pancreatic B-cells.

  1994cites this paper